A Brief Marijuana Intervention for Adolescent Women - 1
|Marijuana Abuse Sexual Risk Behaviors||Behavioral: Behavior Therapy Other: Treatment as Usual||Phase 3|
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
|Official Title:||A Brief Marijuana Intervention for Adolescent Women|
- Marijuna use [ Time Frame: marijuana use at 6 months ]
- Sex-risk behavior [ Time Frame: sex-risk behavior at 6 months ]
|Study Start Date:||September 2004|
|Study Completion Date:||December 2009|
|Primary Completion Date:||December 2009 (Final data collection date for primary outcome measure)|
Placebo Comparator: Treatment as Usual
Participants are administered assessments at baseline, 1, 3 and 6 months
|Other: Treatment as Usual|
Participants complete assessments at baseline, 1, 3 and 6 months, and receive a 2-session behavioral intervention at the baseline and 1-month study appointments.
|Behavioral: Behavior Therapy|
This study holds the promise of developing a brief, efficacious intervention to reduce marijuana use and related sexual risk-taking behavior among the large populaton of late adolescent women who are regular marijuana users. In the abscence of intervention, these women are at heightened risk of contracting HIV and other sexually transmitted infections. Therefore it is crucial to develop an intervention that will reduce their marijuana and subsequent sexual risk taking behavior. The intervention employed in this study represents a novel adaptation of interventions that are well-supported with similar populations. If the current intervention is found to be efficacious, it can be readily integrated into a variety of treatment settings, particularly other primary care settings. In addition, this study will contribute valuable information about the relationship between marijuana use and sexual risk taking behavior and about the mechanisms of change in marijuana use in late adolescent women.
Comparison(s): Participants will be assigned, in this 6 month longitudinal study, to an assessment-only group or an assessment plus intervention group. Those in the intervention group will receive 2 motivational intervention sessions during the first 3 months of their study participation.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00227864
|United States, Rhode Island|
|Rhode Island Hospital|
|Providence, Rhode Island, United States, 02903|
|Principal Investigator:||Michael Stein, M.D.||Rhode Island Hospital|